-
19563-1A selective, orally available inhibitor of MEK1 (IC<sub>50</sub> = 4.2 nM) induces differentiation and apoptosis in cancer cells lines.
-
19563-10A selective, orally available inhibitor of MEK1 (IC<sub>50</sub> = 4.2 nM) induces differentiation and apoptosis in cancer cells lines.
-
19563-25A selective, orally available inhibitor of MEK1 (IC<sub>50</sub> = 4.2 nM) induces differentiation and apoptosis in cancer cells lines.
-
19563-5A selective, orally available inhibitor of MEK1 (IC<sub>50</sub> = 4.2 nM) induces differentiation and apoptosis in cancer cells lines.
-
A5162-25 g
Thomas Scientific
Coccidiostat and thiamine transporter inhibitor. It inhibits thiamine transporters in species of Eimeria, preventing carbohydrate synthesis. (C08-0488-546)
Price: $154.34List Price: $171.49Amprolium is an anti-parasitic coccidiostat used in veterinary medicine. Amprolium is a thiamine analog that inhibits thiamine transporters in species of Eimeria, preventing carbohydrate synthesis. -
A5162-100 g
Thomas Scientific
Coccidiostat and thiamine transporter inhibitor. It inhibits thiamine transporters in species of Eimeria, preventing carbohydrate synthesis. (C08-0489-233)
Price: $410.22List Price: $455.80Amprolium is an anti-parasitic coccidiostat used in veterinary medicine. Amprolium is a thiamine analog that inhibits thiamine transporters in species of Eimeria, preventing carbohydrate synthesis. -
19440-2.5An inhibitor of DGK (Ki = 3.1 µM) and DGAT (IC<sub>50</sub> = 5.
-
19440-500An inhibitor of DGK (Ki = 3.1 µM) and DGAT (IC<sub>50</sub> = 5.
-
16157-1A bisdeoxy derivative of coelenterazine that produces an emission peak near 400 nm following conversion by Renilla luciferase commonly used in BRET2 protocols to evaluate protein-protein interactions.
-
16157-5A bisdeoxy derivative of coelenterazine that produces an emission peak near 400 nm following conversion by Renilla luciferase commonly used in BRET2 protocols to evaluate protein-protein interactions.
-
16157-500A bisdeoxy derivative of coelenterazine that produces an emission peak near 400 nm following conversion by Renilla luciferase commonly used in BRET2 protocols to evaluate protein-protein interactions.
-
16894-1A synthetic derivative of native coelenterazine that exhibits 16-fold higher luminescence intensity (emission maximum ~466 nm half-total time of 0.6-1.2 sec) than native coelenterazine.